Unlock stock picks and a broker-level newsfeed that powers Wall Street.

XETRA - Delayed Quote EUR

Dermapharm Holding SE (DMP.DE)

36.35
-0.15
(-0.41%)
As of 11:49:44 AM GMT+2. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Dr. Hans-Georg Feldmeier CEO & Chairman of the Management Board 1.08M -- --
Mr. Christof Dreibholz CFO, Chief Compliance Officer & Member of Management Board 665k -- 1968
Dr. Andreas Eberhorn Chief Marketing Officer & Member of Management Board 657k -- 1976
Ms. Britta Hamberger Head of Investor Relations & Corporate Communications -- -- --

Dermapharm Holding SE

Lil-Dagover-Ring 7
Grünwald, 82031
Germany
49 89 6 41 86 0 https://ir.dermapharm.de
Sector: 
Healthcare
Full Time Employees: 
3,610

Description

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.

Corporate Governance

Dermapharm Holding SE’s ISS Governance QualityScore as of April 1, 2025 is 10. The pillar scores are Audit: 6; Board: 9; Shareholder Rights: 6; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 15, 2025 at 6:30 AM UTC

Dermapharm Holding SE Earnings Date

June 27, 2025 at 12:00 AM UTC

Ex-Dividend Date

Recent Events

Related Tickers